- Meeting abstract
Chemokines in Rheumatoid Arthritis
Arthritis Research & Therapy volume 1, Article number: S23 (1999)
We examined the role of chemokines, which recruit a variety of cells, including leukocytes and endothelial cells, in rheumatoid arthritis (RA). We determined the role of the angiogenic chemokines IL-8 and epithelial neutrophil activating peptide-78 (ENA-78) in RA using a whole synovial tissue (ST) homogenate model. RA ST homogenates produced greater levels of these chemokines than did normal ST homogenates. Angiogenic chemokines often immunolocalized in proximity to ST blood vessels. RA ST homogenates contained more angiogenic activity in vitro and angiogenic activity in vivo than did normal ST extracts. Hence, IL-8 and ENA-78 are major contributors to the RA ST angiogenic activity in vitro and in vivo. To determine the role of chemokines in the development of arthritis, we examined inflammation in rats. Anti-ENA-78 diminished peritoneal neutrophil recruitment in response to rhENA-78 or lipopolysaccaride. In adjuvant-induced arthritis (AIA), a model for RA, rats produced serum ENA-78 from day 7 post adjuvant induction, even prior to the onset of clinical AIA. Joint ENA-78 was elevated in AIA rats from the onset of clinical arthritis. Prophylactic therapy of rat AIA with anti-ENA-78 prior to clinical disease onset resulted in a reduction of arthritis and a decrease in joint IL-1β and tumor necrosis factor (TNF)-α. These results suggest a role for ENA-78 in the early stages of AIA development. Efforts aimed at eliminating these angiogenic chemokines may be of benefit in the therapy of RA.
Koch AE, Kunkel SL, Burrows JC, et al: The synovial tissue macrophage as a source of the chemotactic cytokine interleukin-8. J Immunol. 1991, 147: 2187-2195.
Koch AE, Kunkel SL, Harlow LA, et al: Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest. 1992, 90: 772-779.
Koch AE, Polverini PJ, Kunkel SL, et al: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992, 258: 1798-1801.
Koch AE, Kunkel SL, Harlow LA, et al: Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. J Clin Invest. 1994, 94: 1012-1018.
Koch AE: Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 1998, 41: 951-962. 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D.
Halloran MM, Szekanecz Z, Strieter RM, et al: The role of epithelial neutrophil activating peptide-78 in rat adjuvant-induced arthritis, a model for human rheumatoid arthritis. J Immunol. 1999, 162: 7492-7500.
Koch AE, Strieter RM: . The role of chemokines in disease. Austin: RG Landes Company (and Chapman and Hall). 1996
About this article
Cite this article
Koch, A. Chemokines in Rheumatoid Arthritis. Arthritis Res Ther 1 (Suppl 1), S23 (1999). https://doi.org/10.1186/ar37